Statement: in cohort 1 of the primary trial there were 10 more cases of Left ventricular dysfunction than Abdominal pain
Primary_evidence: Adverse Events 1:   Total: 70/219 (31.96%)   Anaemia * 0/219 (0.00%)   Febrile neutropenia * 26/219 (11.87%)   Neutropenia * 7/219 (3.20%)   Thrombocytopenia * 1/219 (0.46%)   Cardiac failure * 2/219 (0.91%)   Sinus tachycardia * 1/219 (0.46%)   Left ventricular dysfunction * 2/219 (0.91%)   Abdominal pain * 1/219 (0.46%)   Abdominal pain upper * 1/219 (0.46%)   Colitis * 3/219 (1.37%) Adverse Events 2:   Total: 30/223 (13.45%)   Anaemia * 3/223 (1.35%)   Febrile neutropenia * 3/223 (1.35%)   Neutropenia * 0/223 (0.00%)   Thrombocytopenia * 1/223 (0.45%)   Cardiac failure * 1/223 (0.45%)   Sinus tachycardia * 0/223 (0.00%)   Left ventricular dysfunction * 0/223 (0.00%)   Abdominal pain * 0/223 (0.00%)   Abdominal pain upper * 0/223 (0.00%)   Colitis * 0/223 (0.00%)